FORMULATION OF NUCLEIC ACIDS AND ACEMANNAN

The present invention is related to the medical field, and in particular to the use of new formulations of adjuvants with vaccine antigens. The technical object of the invention is the development of formulations which are capable of potentiating the immune response of the organism to vaccines of nu...

Full description

Saved in:
Bibliographic Details
Main Authors IGLESIAS PEREZ, ENRIQUE, GUILLEN NIETO, GERARDO ENRIQUE, PICHARDO DIAZ, DAGMARA, SANDEZ OQUENDO, BELQUIS, LEAL ANGULO, MARIA DE JESUS, MUZIO GONZALEZ, VERENA LUCILA, AGUILAR RUBIDO, JULIO CESAR, QUINTANA VAZQUEZ, DIOGENES, CROMBET MENENDEZ, LISSETE, MUSACCHIO LASA, ALEXIS, HERRERA BUCH, ANTONIETA, PENTON ARIAS, EDUARDO
Format Patent
LanguageEnglish
French
German
Published 23.02.2005
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is related to the medical field, and in particular to the use of new formulations of adjuvants with vaccine antigens. The technical object of the invention is the development of formulations which are capable of potentiating the immune response of the organism to vaccines of nucleic acids. In order to attain this objective, a formulation has been developed which contains as fundamental components the vaccine nucleic acid and acemannan in adequate proportions, in addition to stabilizing and preservative agents. The formulations of the invention are applicable to the pharmaceutical industry as vaccine formulations both for human and animal use.
Bibliography:Application Number: EP19990942707